| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shuang Xu, William F Jiemy, Annemieke M H Boots, Suzanne Arends, Yannick van Sleen, Pieter H Nienhuis, Kornelis S M van der Geest, Peter Heeringa, Elisabeth Brouwer, Maria Sandovic. Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis. Arthritis care & research. 2024-04-30. PMID:38685696. |
giant cell arteritis (gca) is characterized by granulomatous inflammation of the medium and large-sized arteries accompanied by remodeling of the vessel wall. |
2024-04-30 |
2024-05-03 |
Not clear |
| Pia Wallmeier, Sabrina Arnold, Arlette Tais, Gabriele Ihorst, Marco Janoschke, Fabian Schubach, Peer Aries, Raoul Bergner, Jan Phillip Bremer, Norman Görl, Eva Gutdeutsch, Bernhard Hellmich, Jörg Henes, Bimba Franziska Hoyer, Antje Kangowski, Ina Kötter, Martin Krusche, Tim Magnus, Claudia Metzler, Ulf Müller-Ladner, Matthias Schaier, Ulf Schönermarck, Jens Thiel, Leonore Unger, Nils Venhoff, Julia Weinmann-Menke, Jana Petersen, Peter Lamprecht, Christof Iking-Koner. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients. Clinical and experimental rheumatology. vol 42. issue 4. 2024-04-29. PMID:38683207. |
giant cell arteritis (gca) is one of the most common forms of vasculitis. |
2024-04-29 |
2024-05-02 |
Not clear |
| Maira Karabayas, Hafeez E Ibrahim, Anke J Roelofs, Gary Reynolds, Dana Kidder, Cosimo De Bar. Vascular disease persistence in giant cell arteritis: are stromal cells neglected? Annals of the rheumatic diseases. 2024-04-29. PMID:38684323. |
giant cell arteritis (gca), the most common systemic vasculitis, is characterised by aberrant interactions between infiltrating and resident cells of the vessel wall. |
2024-04-29 |
2024-05-03 |
Not clear |
| Pascal Seitz, Fabian Lötscher, Susana Bucher, Lukas Bütikofer, Britta Maurer, Arsany Hakim, Luca Seit. Ultrasound intima-media thickness cut-off values for the diagnosis of giant cell arteritis using a dual clinical and MRI reference standard and cardiovascular risk stratification. Frontiers in medicine. vol 11. 2024-04-26. PMID:38654833. |
to derive segmental cut-off values and measures of diagnostic accuracy for the intima-media thickness of compressed temporal artery segments for the diagnosis of giant cell arteritis (gca) on the patient level. |
2024-04-26 |
2024-04-28 |
Not clear |
| Sho Shimohama, Noboru Imai, Takuya Tsubata, Kei Shinohara, Asami Moriya, Nobuyasu Yagi, Takashi Konishi, Masahiro Serizawa, Kazuhiro Tashir. Headache-Related Characteristics of Biopsy-Confirmed Giant Cell Arteritis and the Relationship of Transmural Inflammation With Artery Tenderness and Chordal Thickening. Cureus. vol 16. issue 3. 2024-04-26. PMID:38659551. |
giant cell arteritis (gca) is characterized by headaches, but few studies have examined the detailed characteristics of pathologically confirmed cases. |
2024-04-26 |
2024-04-28 |
Not clear |
| Ayaz Aghayev, Britanny Weber, Tiago Lins de Carvalho, Andor W J M Glaudemans, Pieter H Nienhuis, Kornelis S M van der Geest, Riemer H J A Slar. Multimodality imaging to assess diagnosis and evaluate complications of large vessel arteritis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2024-04-25. PMID:38663459. |
giant cell arteritis (gca) and takayasu's arteritis (tak) are the main forms of large-vessel vasculitis, and may lead to lumen narrowing. |
2024-04-25 |
2024-04-28 |
Not clear |
| Idil Esen, Maria Sandovici, Peter Heeringa, Annemieke M H Boots, Elisabeth Brouwer, Yannick van Sleen, Wayel Abdulaha. Impaired IL-6-induced JAK-STAT signaling in CD4 Journal of autoimmunity. vol 146. 2024-04-23. PMID:38653164. |
impaired il-6-induced jak-stat signaling in cd4 the il-12-ifnγ-th1 and the il-6-il-23-th17 axes are considered the dominant pathogenic pathways in giant cell arteritis (gca). |
2024-04-23 |
2024-04-26 |
Not clear |
| Geoffroy Peyrac, Arthur Mageau, Augustin Gaudemer, Khadija Benali, Julien Rohmer, Jean-Francois Alexandra, Andrey Strukov, Sebastien Ottaviani, Thomas Papo, Karim Sacr. Limb arteries involvement assessed by FDG/PET CT at diagnosis of giant cell arteritis and risk of relapse: an observational study. Joint bone spine. 2024-04-17. PMID:38631525. |
introduction steroids and anti-il6 biotherapy are highly effective in obtaining remission in patients with giant cell arteritis (gca) but the risk of relapses remains high. |
2024-04-17 |
2024-04-20 |
Not clear |
| Sonja C Mansfield Smith, Mustafa R Al-Hashimi, Colin D Jones, Chetan B Mukhtya. Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis. Clinical medicine (London, England). vol 23. issue 3. 2024-04-13. PMID:38614772. |
we present the largest study of the frequency and nature of visual complications in a cohort of 350 patients consecutively diagnosed with giant cell arteritis (gca). |
2024-04-13 |
2024-04-16 |
Not clear |
| Vitorino Modesto Dos Santos, Taciana Arruda Modesto Suga. Re: Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand. The New Zealand medical journal. vol 137. issue 1593. 2024-04-11. PMID:38603793. |
the interest in epidemiological data on giant cell arteritis (gca) increased both in new zealand and in latin america, resulting in updated articles like those here commented. |
2024-04-11 |
2024-04-14 |
Not clear |
| Marieke van Nieuwland, Edgar M Colin, Marloes Vermeer, Nils R L Wagenaar, Onno D Vijlbrief, Jordy K van Zandwijk, Riemer H J A Slart, Hendrik Koffijberg, Erik Groot Jebbink, Kornelis S M van der Geest, Elisabeth Brouwer, Dennis Boumans, Celina Alve. A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis. Rheumatology (Oxford, England). 2024-04-10. PMID:38597882. |
this study directly compares diagnostic performance of colour duplex ultrasound (cdus), fluor-18-deoxyglucose positron emission tomography computed tomography (fdg-pet/ct) and magnetic resonance imaging (mri) in patients suspected of giant cell arteritis (gca). |
2024-04-10 |
2024-04-12 |
Not clear |
| Pavlos Stamatis, Moman Aladdin Mohammad, Karl Gisslander, Peter A Merkel, Martin Englund, Carl Turesson, David Erlinge, Aladdin J Mohamma. Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden. RMD open. vol 10. issue 2. 2024-04-10. PMID:38599652. |
to determine the incidence rate (ir) of myocardial infarction (mi), relative risk of mi, and impact of incident mi on mortality in individuals with biopsy-confirmed giant cell arteritis (gca). |
2024-04-10 |
2024-04-13 |
Not clear |
| Yuki Sato, Maria Tada, Jorg J Goronzy, Cornelia M Weyan. Immune checkpoints in autoimmune vasculitis. Best practice & research. Clinical rheumatology. 2024-04-10. PMID:38599937. |
giant cell arteritis (gca) is a prototypic autoimmune disease with a highly selective tissue tropism for medium and large arteries. |
2024-04-10 |
2024-04-13 |
Not clear |
| Thomas Ness, Bernhard Nöll. Giant Cell Arteritis. Klinische Monatsblatter fur Augenheilkunde. 2024-04-09. PMID:38593832. |
giant cell arteritis (gca) is the most common primary vasculitis and is associated with potential bilateral blindness. |
2024-04-09 |
2024-04-12 |
Not clear |
| Yoshiyuki Abe, Takao Fujii, Yoshia Miyawaki, Takahiko Sugihara, Haruhito A Uchida, Yasuhiro Maejima, Yoshiko Watanabe, Takuya Hashimoto, Takako Miyamae, Yoshikazu Nakaoka, Masayoshi Harigai, Naoto Tamur. The real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web-questionnaire survey. Modern rheumatology. 2024-04-09. PMID:38590042. |
to access the real-world clinical management of physicians who treat takayasu arteritis (tak) and giant cell arteritis (gca) after the publication of the japanese circulation society (jcs) 2017 guidelines for the management of vasculitis syndrome. |
2024-04-09 |
2024-04-11 |
Not clear |
| Sophie Gallou, Christian Agard, Anael Dumont, Samuel Deshayes, Jonathan Boutemy, Gwénola Maigné, Nicolas Martin Silva, Alexandre Nguyen, Rémi Philip, Olivier Espitia, Achille Aouba, Hubert de Boysso. Evolution and outcomes of aortic dilations in giant cell arteritis. European journal of internal medicine. 2024-04-05. PMID:38580542. |
to identify factors associated with the progression of giant cell arteritis (gca)-related or associated aortic dilations. |
2024-04-05 |
2024-04-10 |
Not clear |
| Daniel Blockmans, Lien Moreel, Albrecht Betrains, Steven Vanderschueren, Walter Coudyzer, Lennert Boeckxstaens, Koen Van Laer. Association between vascular FDG uptake during follow-up and the development of thoracic aortic aneurysms in giant cell arteritis. Frontiers in medicine. vol 11. 2024-04-04. PMID:38572159. |
a positive pet scan at diagnosis was associated with a greater yearly increase in ascending and descending aortic diameter and thoracic aortic volume in patients with giant cell arteritis (gca). |
2024-04-04 |
2024-04-06 |
Not clear |
| Pierre-André Jarrot, Adrien Mirouse, Sébastien Ottaviani, Simon Cadiou, Jean-Hugues Salmon, Eric Liozon, Simon Parreau, Martin Michaud, Benjamin Terrier, Pierre-Edouard Gavand, Ludovic Trefond, Virginie Lavoiepierre, Jeremy Keraen, Daniel Rekassa, Bastien Bouldoires, Thierry Weitten, Damien Roche, Antoine Poulet, Caroline Charpin, Vincent Grobost, Marion Hermet, Magali Pallure, Chloe Wackenheim, Ludovic Karkowski, Pierre Grumet, Thomas Rogier, Nabil Belkefi, Vincent Pestre, Emilie Broquet, Amélie Leurs, Sophie Gautier, Valérie Gras, Pierre Gilet, Jan Holubar, Nadia Sivova, Nicolas Schleinitz, Jean-Marc Durand, Brice Castel, Alexandre Petrier, Robin Arcani, Baptiste Gramont, Philippe Guilpain, Hubert Lepidi, Pierre-Jean Weiller, Joelle Micallef, David Saadoun, Gilles Kaplansk. Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey. Human vaccines & immunotherapeutics. vol 20. issue 1. 2024-04-02. PMID:38563792. |
we conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (rr) and to determine the clinical profile of polymyalgia rheumatica (pmr) and giant cell arteritis (gca) in covid-19-vaccinated individuals. |
2024-04-02 |
2024-04-04 |
Not clear |
| Mats Junek, Lillian Barra, Alexander Kopp, Tina Felfeli, Jodi Gatley, Jessica Widdifiel. Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada. The Journal of rheumatology. 2024-04-01. PMID:38561188. |
to estimate the additional health care system costs associated with giant cell arteritis (gca) in the year pre-diagnosis, post diagnosis, and over long-term follow up compared to individuals with similar demographics and comorbidities without gca. |
2024-04-01 |
2024-04-04 |
Not clear |
| Sharon Cowley, Patricia Harkins, Colm Kirby, Richard Conway, David J Kan. Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment? Annals of the rheumatic diseases. 2024-03-29. PMID:38553044. |
there is a growing appreciation that both giant cell arteritis (gca) and polymyalgia rheumatica (pmr) are closely interrelated conditions that have significant overlap in aetiology, clinical characteristics and treatment regimens. |
2024-03-29 |
2024-04-01 |
Not clear |